MPO, myeloperoxidase, 4353

N. diseases: 653; N. variants: 25
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.360 AlteredExpression disease BEFREE In human specimens, CRC patients exhibiting an active CRCSC signal (Snail<sup>+</sup>IL8<sup>+</sup>) showed elevated tumor infiltration of MPO<sup>+</sup> neutrophils, and high (in the top 10%) MPO expression predicted poor survival of CRC patients. 30683126 2019
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.360 GeneticVariation disease BEFREE Taken together, our findings indicate that <i>MPO</i> SNP rs2333227 serves as a marker of enhanced risk for development of colorectal cancer.<b>Significance:</b> MPO polymorphisms are a guide for high risk and poor prognosis in patients colorectal cancer.<i></i>. 29540402 2018
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.360 Biomarker disease BEFREE CD66b and myeloperoxidase (MPO) were assessed as candidate neutrophil markers in CRC using immunohistochemistry. 26939802 2016
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.360 Biomarker disease BEFREE The epigenetic/genetic associations related to elevated MPO staining in UC-CRC may offer new methods for risk stratification and adjunctive screening tools. 21425209 2012
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.360 GeneticVariation disease BEFREE The myeloperoxidase-463 G>A polymorphism influences risk of colorectal cancer in southern China: a case-control study. 22126566 2011
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.360 Biomarker disease BEFREE Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 18768495 2008
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.360 GeneticVariation disease UNIPROT